Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 26;104(9):1505-10.
doi: 10.1038/bjc.2011.68.

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

T Evans  1 , O Sany, P Pearmain, R Ganesan, A Blann, S Sundar
Affiliations

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

T Evans et al. Br J Cancer. .

Abstract

Background: Endometrial cancer is the most common gynaecological cancer in the western world, the incidence increasing in the United Kingdom by over 40% since 1993. Two types of endometrial cancer exist - oestrogen-dependent type 1 with good prognosis and non-oestrogen-dependent type 2 with poor prognosis. The histopathological distribution of the increase in endometrial cancer is unknown. This study investigates the observed incidence trends of the two types, the age, stage, and socioeconomic distribution of this increase and survival outcome.

Methods: Data were analysed from 6867 women with endometrial cancer registered between 1994 and 2006, at a UK population-based cancer registry.

Results: Increased endometrial cancer incidence is confined to type 1 cancers with a significant increase in age standardised incidence rate (ASR) from 12.0 per 100,000 (confidence interval (CI) 10.7-13.2) in 1994 to 16.3 per 100,000 (CI 14.9-17.7), P<0.001 in 2006, while ASR of type 2 cancer changed from 2.5 per 100,000 (CI 2.0-3.1) in 1994 to 2.2 per 100,000 (CI 1.7-2.7) in 2006, which was not statistically significant P>0.05. Increase in type 1 cancer is most marked in age groups 60-69 years (P<0.001) and 70-79 years (P<0.001) and distributed equally among socioeconomic quintiles. While outcome for type 1 cancer has improved, 1-year survival in type 2 cancer is unchanged from 73.1% in 1994 to 74.3%, P=0.089 and 5-year survival decreased from 55.1% to 40.9%, P=0.001.

Conclusion: Increased incidence in endometrial cancer is confined to type 1 cancers, seen most in the 60-79 age groups and across all socioeconomic quintiles. Survival in type 2 cancer has decreased significantly. Urgent research is needed to investigate prevention strategies in type 1 and improve therapy in type 2 cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Differential trends in endometrial cancer incidence across the two types. Age standardised incidence rates and confidence intervals are shown.
Figure 2
Figure 2
Analysis of increase in type 1 endometrial cancer rates by socioeconomic distribution. Confidence intervals for both graphs overlap at each time point.
Figure 3
Figure 3
Analysis of type 1 endometrial cancer incidence by age groups.
Figure 4
Figure 4
Five-year relative survival of endometrial cancer types 1 and 2.
See this image and copyright information in PMC

References

    1. Amant F, Vandenput I, Van Gorp T, Vergote I, Moerman P (2006) Endometrial carcinosarcoma with osteoclast-like giant cells. Eur J Gynaecol Oncol 27(1): 92–94 - PubMed
    1. Archie Jr JP (1981) Mathematic coupling of data: a common source of error. Ann Surg 193(3): 296–303 - PMC - PubMed
    1. Bansal N, Yendluri V, Wenham RM (2009) The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16(1): 8–13 - PubMed
    1. Bjorge T, Engeland A, Tretli S, Weiderpass E (2007) Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120(2): 378–383 - PubMed
    1. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1): 10–17 - PubMed

Publication types

MeSH terms